§ 130c Abs. 1 SGB V Trelegy Ellipta(R) Wirkstoffkombination: Vilanterol, Umeclidiniumbromid und Fluticasonfuroat ATC-Code: R03AL08
Tender information
TED EUMünchen, Germany
- Type
- 25
- Procedure
- neg-wo-call
- Ref. number
- 198383-2025
- CPV
- 33600000
Arzneimittelrabattvertrag § 130c Abs. 1 SGB V Trelegy Ellipta(R) Wirkstoffkombination: Vilanterol, Umeclidiniumbromid und Fluticasonfuroat ATC-Code: R03AL08